Neuronet launches campaign: “The value of public-private collaboration & findings highlights”

The Neuronet project (https://www.imi-neuronet.org/) is currently comprised of 18 IMI projects, including PD-MitoQUANT. Today, September 11, 2020, they have launched a new platform to boost collaboration across research projects focusing on neurodegenerative diseases.

Neuronet’s communication team and our community of communication representatives from the Innovative Medicines Initiative projects on neurodegeneration are pleased to celebrate the great people behind the projects through an annual Neuronet campaign on social media. A profile of Dr Orla Watters, a member of the PD-MitoQUANT research team at the RCSI (Royal College of Surgeons Ireland) will feature early in the campaign. Later, it featured Dr Shruti Desai of Radboud University Nijmegen Medical Center and Dana Bar-On at Teva Pharmaceutical Industries.

Neuronet initiated the new campaign to highlight the value of public-private collaboration and to capitalise on the increased public attention on neurodegenerative diseases during World Alzheimer’s Month. The social media campaign will conclude on October 20^th, in time to build up awareness towards Neuronet’s yearly event. The main social media platform we use is Twitter.  The Twitter campaign will highlight some of the great findings, interesting activities and tools, none of which would have been possible without public-private collaboration.

Follow Neuronet on Twitter to keep up to date with the series. https://twitter.com/IMI2_NEURONET Keep an eye on #WeAreNeuronet too.